The Functional Role of microRNAs and mRNAs in Diabetic Kidney Disease: A Review

被引:2
作者
Rai, Bhuvnesh [1 ]
Srivastava, Jyotika [1 ]
Saxena, Pragati [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Stem Cell Res Ctr, Dept Hematol, Lucknow, India
关键词
Diabetic kidney disease; miRNA-mRNA; genes target; diabetes; bioinformatics; fibrosis; MIR-200; FAMILY; MESENCHYMAL TRANSITION; RENAL FIBROSIS; CELL-PROLIFERATION; REPRESSORS ZEB1; TARGETING ZEB1; NEPHROPATHY; BIOMARKERS; EXPRESSION; MECHANISMS;
D O I
10.2174/0115733998270983231009094216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is a group of diseases marked by poor control of blood glucose levels. Diabetes mellitus (DM) occurs when pancreatic cells fail to make insulin, which is required to keep blood glucose levels stable, disorders, and so on. High glucose levels in the blood induce diabetic effects, which can cause catastrophic damage to bodily organs such as the eyes and lower extremities. Diabetes is classified into many forms, one of which is controlled by hyperglycemia or Diabetic Kidney Disease (DKD), and another that is not controlled by hyperglycemia (non-diabetic kidney disease or NDKD) and is caused by other factors such as hypertension, hereditary. DKD is associated with diabetic nephropathy (DN), a leading cause of chronic kidney disease (CKD) and end-stage renal failure. The disease is characterized by glomerular basement membrane thickening, glomerular sclerosis, and mesangial expansion, resulting in a progressive decrease in glomerular filtration rate, glomerular hypertension, and renal failure or nephrotic syndrome. It is also represented by some microvascular complications such as nerve ischemia produced by intracellular metabolic changes, microvascular illness, and the direct impact of excessive blood glucose on neuronal activity. Therefore, DKD-induced nephrotic failure is worse than NDKD.MicroRNAs (miRNAs) are important in the development and progression of several diseases, including diabetic kidney disease (DKD). These dysregulated miRNAs can impact various cellular processes, including inflammation, fibrosis, oxidative stress, and apoptosis, all of which are implicated during DKD. MiRNAs can alter the course of DKD by targeting several essential mechanisms. Understanding the miRNAs implicated in DKD and their involvement in disease development might lead to identifying possible therapeutic targets for DKD prevention and therapy. Therefore, this review focuses specifically on DKD-associated DN, as well as how in-silico approaches may aid in improving the management of the disease.
引用
收藏
页码:136 / 144
页数:9
相关论文
共 134 条
[1]  
Ahmet AK., Diabetes, cardiomyopathy, and heart failure
[2]   MicroRNAs in kidney function and disease [J].
Akkina, Sanjeev ;
Becker, Bryan N. .
TRANSLATIONAL RESEARCH, 2011, 157 (04) :236-240
[3]   Diabetic Kidney Disease Challenges, Progress, and Possibilities [J].
Alicic, Radica Z. ;
Rooney, Michele T. ;
Tuttle, Katherine R. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (12) :2032-2045
[4]  
Allison J.H., 2015, Clin. Diabetes Endocrinol, P1
[5]  
Andrey T., 2014, Front. Genet, P5
[6]  
[Anonymous], 2010, BLOOMBERG
[7]   Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes [J].
Argyropoulos, Christos ;
Wang, Kai ;
Bernardo, Jose ;
Ellis, Demetrius ;
Orchard, Trevor ;
Galas, David ;
Johnson, John P. .
JOURNAL OF CLINICAL MEDICINE, 2015, 4 (07) :1498-1517
[8]   Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes [J].
Argyropoulos, Christos ;
Wang, Kai ;
McClarty, Sara ;
Huang, David ;
Bernardo, Jose ;
Ellis, Demetrius ;
Orchard, Trevor ;
Galas, David ;
Johnson, John .
PLOS ONE, 2013, 8 (01)
[9]   Effect of diabetes status and hyperglycemia on global DNA methylation and hydroxymethylation [J].
Arturo Pinzon-Cortes, Jairo ;
Perna-Chaux, Angelina ;
Steven Rojas-Villamizar, Nicolas ;
Diaz-Basabe, Angelica ;
Carolina Polania-Villanueva, Diana ;
Fernanda Jacome, Maria ;
Olimpo Mendivil, Carlos ;
Groot, Helena ;
Lopez-Segura, Valeriano .
ENDOCRINE CONNECTIONS, 2017, 6 (08) :708-725
[10]   Circulating miRNAs in diabetic kidney disease: case-control study and in silico analyses [J].
Assmann, Tais S. ;
Recamonde-Mendoza, Mariana ;
Costa, Aline R. ;
Punales, Marcia ;
Tschiedel, Balduino ;
Canani, Luis H. ;
Bauer, Andrea C. ;
Crispim, Daisy .
ACTA DIABETOLOGICA, 2019, 56 (01) :55-65